论文部分内容阅读
目的:对产后出血预防中缩宫素与米索前列醇的应用效果进行分析。方法:选取我院于2012年2月～2013年6月收治顺产产妇118例,随机分为2组,对照组58例采用缩宫素预防产后出血,观察组60例采用米索前列醇预防产后出血,对比2组产妇产后血压、治疗效果、出血量与止血时间。结果:对比2组产妇术后各项指标,观察组出血量、止血时间均小于对照组(P<0.05),2组产妇术后血压与血红蛋白数量间差异不显著(P>0.05),观察组产后出血预防有效率显著高于对照组(P<0.05)。结论:在产后出血预防中,相较于缩宫素而言,米索前列醇预防产后出血更为有效,可实现快速止血,具有安全、高效特点,值得在临床中推广。
Objective: To analyze the effect of oxytocin and misoprostol in preventing postpartum hemorrhage. Methods: 118 cases of primiparous women were treated in our hospital from February 2012 to June 2013, and were randomly divided into two groups. In the control group, oxytocin was used to prevent postpartum hemorrhage. In the observation group, 60 cases were treated with misoprostol to prevent postpartum Bleeding, compared with postpartum blood pressure in two groups of maternal, treatment, bleeding and bleeding time. Results: Compared with the control group, bleeding and bleeding time in the observation group were significantly lower than those in the control group (P <0.05). There was no significant difference between the two groups in postoperative blood pressure and hemoglobin (P> 0.05) Postpartum hemorrhage prevention efficiency was significantly higher than the control group (P <0.05). Conclusion: In the prevention of postpartum hemorrhage, compared with oxytocin, misoprostol is more effective in preventing postpartum hemorrhage and can achieve rapid hemostasis. It is safe and effective and worthy of promotion in clinic.